EN
Back to the archive

The archive · Developer & Business Tools · Product decision · 2024–2025

Neosync's anonymized-dev-data bet ended in a Grow Therapy acquisition

Neosync anonymized and subset production data so devs could test safely; after a 2024 Show HN and 4.1k stars, Grow Therapy acquired it.

Neosync

The betThat teams would run on anonymized, subset, synthetic production data — so Neosync built an open-source transform-in-flight pipeline instead of a copy tool.No longer exists

What the business is

Neosync is an open-source (MIT), developer-first platform that anonymizes PII, generates synthetic data and subsets production databases as it streams them into dev, staging and CI environments, with a hosted cloud and managed in-VPC deployment.

How it started

Evis and Nick announced Neosync in a 2024-05-22 Show HN. Their diagnosis: features work locally and on staging, then break in production because seed data is not representative; and when production bugs appear, teams cannot reproduce them without production-like data. Real production data is off-limits for privacy and security reasons and often too large, so they set out to make anonymized, subset, synthetic data the safe substitute.

What happened

Between the launch and its archival the project grew into a full data orchestration platform: an async, event-sourced pipeline with retries and playback, declarative GitOps configs, custom transformers in JavaScript or via LLMs, integrations for Postgres, MySQL and S3, and 2,521 commits at the archived snapshot.

How it ended up

Per the repository disclaimer, Neosync was acquired by Grow Therapy; the owner archived nucleuscloud/neosync on 2025-08-30 as read-only and the README states the project is no longer actively maintained, thanking its OSS and Cloud supporters. No deal terms or revenue figures appear in the reviewed sources.

Background

Neosync is an open-source data platform that anonymizes PII, generates synthetic data and subsets production databases for use in dev, staging and CI. Builders Evis and Nick launched it on Hacker News on 2024-05-22 with a simple diagnosis: teams test against seed scripts whose fake data never matches messy production, so features break in production and bugs cannot be reproduced locally — yet privacy and scale rules keep real data out of lower environments.

The bet was that anonymized, production-like data was the answer, and Neosync made it safe and convenient: data streams from a source database to one or more destinations while column-level transformers (40+ pre-built, or custom in JavaScript or via LLMs) anonymize PII or generate synthetic values; SQL filters subset rows, and referential integrity is preserved automatically. The launch post stressed that Neosync never stores the sensitive data it streams, and the MIT-licensed project runs on Docker Compose, bare metal or Kubernetes with a hosted free tier and managed in-VPC deployment.

The project accumulated 2,521 commits and reached 4.1k stars with 232 forks on GitHub. Per the repository disclaimer, Neosync was acquired by Grow Therapy; on 2025-08-30 the owner archived the repository, which is now read-only, and the README says it is no longer actively maintained. The reviewed sources disclose no deal terms, revenue or user numbers.

What has to be true

  • Seed data misses production edge cases, so features break in prod and bugs cannot be reproduced locally; teams already feel this pain on every database-backed project.
  • Privacy and scale rules make raw production data unusable in dev and CI, so anonymizing, subsetting and synthesizing data in flight turns a blocker into a safe workflow.
  • Shipping as MIT open source with Docker, Kubernetes, Terraform, a CLI and a GitHub Action put the tool inside workflows teams already ran, lowering adoption cost.
  • Regulatory scope (HIPAA, GDPR, DPDP, FERPA) made safe lower-environment data a board-level need, not just a developer nicety.

What can be applied

Give developers safe, production-like state instead of asking them to copy real data: the anonymize-and-subset wedge turned a compliance burden into a dev-experience win.

Aftermath

As of the 2026-09-05 snapshot, nucleuscloud/neosync is archived and read-only with 4.1k stars, 232 forks and 2,521 commits; its README says Neosync was acquired by Grow Therapy and is no longer actively maintained, thanking OSS and Cloud supporters. The disclaimer discloses no deal terms and no independent coverage of the acquisition appears in the reviewed sources.

Sources

spotted an error? The archive wants to know.

Your turn

You just read one. Describe what you are building, and see who is betting on the same thing.

Free account · 3 free questions · no card

Related cases